about
Cancer stem cell metabolism: a potential target for cancer therapyRepositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.Rate of entropy model for irreversible processes in living systems.Targeting cancer cell mitochondria as a therapeutic approach: recent updates.Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul.Cancer Metabolism: Fueling More than Just GrowthMitochondrial dynamics as regulators of cancer biology.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells.Metabolic Plasticity of Stem Cells and Macrophages in Cancer.Aging, Metabolism, and Cancer Development: from Peto's Paradox to the Warburg Effect.A functional connection between dyskerin and energy metabolism.The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium.Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening.The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.Stimuli-responsive chitosan-based nanocarriers for cancer therapy.miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming.ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.Identification and characterisation of NANOG+/ OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines.Characterization of HIF-1α/Glycolysis Hyperactive Cell Population via Small-Molecule-Based Imaging of Mitochondrial Transporter Activity.Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Cancer Stem Cell Metabolism and Potential Therapeutic Targets.Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells.Beyond growth signaling: Paneth cells metabolically support ISCs.A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RXPhosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cellsMetabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study
P2860
Q28079045-1C7441DA-7699-4DB8-8E04-CB53734BC6AEQ33914038-FFBED14E-D265-4EF2-B0A1-9A068F2A603FQ37615676-7CC8F163-1964-4B49-BB71-C8EC7E46B1DBQ38638557-7377A0AD-71E8-41BE-B421-A68032CDBF71Q38668524-DD636C87-D08F-4190-92D0-D83BBBF1E299Q38743394-FDEB31A9-F767-4231-AA64-F0B5A0F7A6AFQ39026430-7ED867FC-7055-4D41-8912-C73675366D9BQ39061395-A4F39A99-AC85-480D-94DB-F019CE4FBD5CQ39084933-100D41BA-0FFA-46CE-968B-50B7D76F5A6BQ39205930-0EF6235D-6422-4056-BEB8-3332F91B67ACQ39378337-59BB4162-0D86-4F1F-AD73-63480108CE13Q41071162-11D8E40D-736E-42DF-B4F3-2F84E09AFE09Q41352553-20CB1C4B-F540-4A03-B2F7-04D7AD4908BAQ42364240-B39DFB06-DB79-4EA4-B642-3B07763C4D7AQ45218312-5FE36F59-8E54-4815-BC30-786297F0B534Q46279053-42A83983-61E0-4121-B33B-AA27D53EF361Q47448276-631878B2-F00F-4C77-9D4A-E1BECC5A288CQ47740376-3F58BCAA-68C5-43E3-A658-8B4061DC2213Q48159512-B5FCA951-6DEB-41F8-9053-ACAADDC5ECDBQ48234693-8734DEB5-C747-462B-BFE8-A490157C3E65Q48610619-BB930BB1-021E-4748-A173-2AC81AF6542BQ49787658-AC8959EE-2F8A-4516-B3E3-310F7B32655BQ50045699-55275FF1-4CB8-46F6-927B-E52C00CE5D72Q50064930-48B89FC9-BAF4-4232-9EAF-95DB9ED4C804Q50130132-10731BDE-9560-4E11-9225-F919F211E388Q50326638-C337770F-60D4-4E4D-A7F0-1BE9C3F5699FQ52624299-F2C9B37C-69E6-48F9-97CE-DF82F476A9A9Q52661722-7374589B-A1C0-480D-91DD-6D0C42784D5EQ55254924-C32E606F-2952-4A87-8A19-649541E238BFQ55296899-ABB7852B-410F-44C8-8C26-210D4F204594Q55396904-472E3B80-67B0-4330-A1C9-2FC905595A3FQ55454960-E26B20DA-0DA7-45F8-9D85-7D11D0669484Q55510934-04FF1274-063C-428D-96B2-BEC47CAC7395Q57148983-5BCB0098-6A78-4C58-93C1-98731496D988Q58700460-7B032850-47A0-42B1-BA43-C364D96D569BQ59133810-4E71657D-CBA7-4762-83A3-E9E1C8ECD3CD
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hallmarks of cancer stem cell metabolism.
@en
type
label
Hallmarks of cancer stem cell metabolism.
@en
prefLabel
Hallmarks of cancer stem cell metabolism.
@en
P2860
P356
P1476
Hallmarks of cancer stem cell metabolism
@en
P2093
Christopher Heeschen
David Barneda
P2860
P2888
P304
P356
10.1038/BJC.2016.152
P407
P577
2016-05-24T00:00:00Z
P6179
1041215485